Open AccessP805: ALEMTUZUMAB IN RELAPSED SEVERE APLASTIC ANEMIA: LONG‐TERM RESULTS OF A PHASE II STUDY
Author(s) -
Aggarwal N.,
Manley A. L.,
Durrani J.,
Shalhoub R.,
Rios O.,
Lotter J.,
Patel B.,
Wu C.,
Young N.,
Groarke E.
Publication year - 2022
Publication title -
hemasphere
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.677
H-Index - 11
ISSN - 2572-9241
DOI - 10.1097/01.hs9.0000846104.45481.e4
Subject(s) - medicine , alemtuzumab , cumulative incidence , aplastic anemia , gastroenterology , pancytopenia , hematopoietic stem cell transplantation , cd52 , bone marrow , clinical endpoint , transplantation , oncology , clinical trial